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should be properly informed about the impact of atopicdermatitis and the methods of its 
prevention. 
Aim of the study. To establish the clinical features and pharmacotherapeutic modalities of 
atopic dermatitis in children. 
Materials and methods. The analysis of 57 clinical cases of atopic dermatitis in children with 
duration of 2years was performed in ambulatory conditions. 
Results. Out of the group of 40 children with atopic dermatitis, to whom the diagnosis was 
established based on the Haniffin and Raika criteria, it was established that 17 (42.5%) belong 
to the extrinsic subtype of atopic dermatitis, and a number of 23 (57.5%) ) of patients belong 
to the intrinsic subtype. 11 cases with AD are associated with other allergic diseases (27%), 
respectively 8 are with allergic rhinitis (20%), and 3 with bronchial asthma (7.5%). Topical 
treatment is a compulsory and important part of complex DA therapy. The most used topical 
preparations were: creams with mometasone, clobetasol and fluticasone. Therapy with sedative 
and nonsedatav antihistamines (generations 1 and 2) presents basic therapy in atopic dermatitis 
in children. The most commonly used was I generation antihistamines such as: clemastine 
(26%), chloropyramine (42%) and ciproheptadine (32%), which are prescribed mainly in acute 
forms of AD. In subacute and chronic forms, second-generation antihistamines are usually 
used. The most commonly used drugs are: loratadine (64%), desloratadine (21%), cetirizine 
(28%) and levocetirizine (14%). Systemic antihistamine therapy, with both sedative and non-
sedative effects, is the basic therapy for AD in children. The emollient remedies and 
contemporary curative cosmetics used are products from Bioderma, Avene, ISIS Pharma etc. 
They are used daily, not less than 2 times per day. It is administered as a whole with 
glucocorticoids and during the remission period, in the absence of the symptoms of the disease. 
Conclusions. The study determined that 42.5% of cases belong to the extrinsic subtype of 
atopic dermatitis, and 57.5% of patients belong to the intrinsic subtype. Ensuring adequate 
antiallergic management in combination with avoiding the adverse action of allergic factors 
contributes to reducing the incidence of atopic dermatitis morbidity in children. 
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Introduction. People use antipsychotic medications to manage schizophrenia as well as other 
disorders. The most bothersome side effect, especially for women is the weight gain associated 
with the use of antipsychotic medications. Currently there is no first line medication for weight 
control with antipsychotics. The mechanism of the weight gain by antipsychotics is unclear, 
however, it might be due to blocking of central histamine 1 (H1) or serotonin (5HT2c) 
receptors. It is suspected that naltrexone, an opioid antagonist, suppresses the desire for high 
fat foods via acting on D2 receptors. Metformin, however, is involved in appetite suppression 
and slowing of gastric emptying via promoting glucagon-like peptide-1 secretion. Thus, both 
these mechanisms might be able to counteract or prevent weight gain associated with 
antipsychotics use.  
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Aim of the study. To determine whether metformin is more effective in weight loss after the 
use of antipsychotic medications.  
Materials and methods. PubMed database was used to search meshterms “antipsychotic, 
weight gain, metformin,” which were combined with “and” to result in 14 articles. After the 
addition of the filter “published within the last 5 years” was added, 5 articles were left. The 
meshterms “antipsychotic, weight gain, naltrexone” were combined with “and” to result in 3 
articles. There were no articles with both drugs together.  Embase database was searched from 
1996 till 2017 week 02. Mapped key words “antipsychotic, weight gain, naltrexone” were 
filtered with randomized controlled trials within the last 5 years and combined with “and” 
which resulted in one article. Similarly key words “antipsychotic, weight gain, metformin” 
resulted in 5 articles. Two articles were not on the correct topic.  
Results. Metformin is shown to significantly reduce weight in schizophrenic patients by about 
3 kg (2 RCTs; n=148, 45 women; and n=72, 32 women). Second study shows that metformin 
reduced initial body weight greater than was clinically significant (>7%, p=0.003). Naltrexone 
showed significant weight loss of 3.4 kg (CI=-5.16, -1.65, p=0.001) (1 RCT; n=24). No studies 
compared metformin and naltrexone in one trial. Metformin was shown to have more additional 
health benefits.  
Conclusions. Both metformin and naltrexone show statistically significant weight reduction in 
patients taking antipsychotics. However, metformin appears in more studies than naltrexone 
and shows additional health benefits like reduction of triglycerides. Thus, metformin appears 
to be more effective in weight control for women with schizophrenia. Pharmacists might be 
able to recommend metformin as an adjunct to the antipsychotic therapy.  
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Introduction. Gastro-duodenum ulcer is a break in the inner lining of the stomach, the first 
part of the small intestine, or sometimes the lower esophagus. The most common symptoms of 
a duodenal ulcer are waking at night with upper abdominal pain (often described as a burning 
or dull ache), belching, vomiting, weight loss, or poor appetite. Worldwide, prevalence of the 
disease is estimated at 6-14% of the adult population and for Republic of Moldova is 100-120 
sick persons per 10,000 population  
Aim of the study. Highlighting epidemiological factors, mechanism of development and 
treatment methods of gostro-duodenum ulcer  
Materials and methods. Analysis of data from the observation files of 60 patients hospitalized 
in Internal Diseases Department no.1 of "Clinical Hospital of the Ministry of Health", 
Gastrology unit, during 2019. The evaluated parameters were: gender, age, smoker or non-
smoker, place of living, basic diagnosis (type of ulcer developed), the etiology of the disease, 
complications, treatment, recommendations for discharge  
Results. The analysis of the distribution of cases of gastro-duodenum ulcer by sex showed the 
predominance of the male (62%) compared to the female (38%). The total number of patients 
